Ruyssen-Witrand A - Search Results

1

Increased Cardiovascular Risk in Psoriatic Arthritis: Results From a Case-Control Monocentric Study.

Degboé Y, Koch R, Zabraniecki L, Jamard B, Couture G, Ruidavets JB, Ferrieres J, Ruyssen-Witrand A, Constantin A. Degboé Y, et al. Front Med (Lausanne). 2022 May 19;9:785719. doi: 10.3389/fmed.2022.785719. eCollection 2022. Front Med (Lausanne). 2022. PMID: 35665348 Free PMC article.

2

Fcγ receptor type IIIA polymorphism influences treatment outcomes in patients with rheumatoid arthritis treated with rituximab.

Ruyssen-Witrand A, Rouanet S, Combe B, Dougados M, Le Loët X, Sibilia J, Tebib J, Mariette X, Constantin A. Ruyssen-Witrand A, et al. Ann Rheum Dis. 2012 Jun;71(6):875-7. doi: 10.1136/annrheumdis-2011-200337. Epub 2012 Feb 25. Ann Rheum Dis. 2012. PMID: 22368231 Clinical Trial.

3

New insights into the genetics of immune responses in rheumatoid arthritis.

Ruyssen-Witrand A, Constantin A, Cambon-Thomsen A, Thomsen M. Ruyssen-Witrand A, et al. Tissue Antigens. 2012 Aug;80(2):105-18. doi: 10.1111/j.1399-0039.2012.01939.x. Tissue Antigens. 2012. PMID: 22835281 Free article. Review.

4

Association between -871C>T promoter polymorphism in the B-cell activating factor gene and the response to rituximab in rheumatoid arthritis patients.

Ruyssen-Witrand A, Rouanet S, Combe B, Dougados M, Le Loët X, Sibilia J, Tebib J, Mariette X, Constantin A. Ruyssen-Witrand A, et al. Rheumatology (Oxford). 2013 Apr;52(4):636-41. doi: 10.1093/rheumatology/kes344. Epub 2012 Dec 22. Rheumatology (Oxford). 2013. PMID: 23264555 Clinical Trial.

5

Epistatic interaction between BANK1 and BLK in rheumatoid arthritis: results from a large trans-ethnic meta-analysis.

Génin E, Coustet B, Allanore Y, Ito I, Teruel M, Constantin A, Schaeverbeke T, Ruyssen-Witrand A, Tohma S, Cantagrel A, Vittecoq O, Barnetche T, Le Loët X, Fardellone P, Furukawa H, Meyer O, Fernández-Gutiérrez B, Balsa A, González-Gay MA, Chiocchia G, Tsuchiya N, Martin J, Dieudé P. Génin E, et al. PLoS One. 2013 Apr 30;8(4):e61044. doi: 10.1371/journal.pone.0061044. Print 2013. PLoS One. 2013. PMID: 23646104 Free PMC article.

6

Association of IL-2RA and IL-2RB genes with erosive status in early rheumatoid arthritis patients (ESPOIR and RMP cohorts).

Ruyssen-Witrand A, Lukas C, Nigon D, Dawidowicz K, Morel J, Sibilia J, Jamard B, Cambon-Thomsen A, Cantagrel A, Dieudé P, Constantin A. Ruyssen-Witrand A, et al. Joint Bone Spine. 2014 May;81(3):228-34. doi: 10.1016/j.jbspin.2013.10.002. Epub 2013 Nov 5. Joint Bone Spine. 2014. PMID: 24200909

7

Aiming for SDAI remission versus low disease activity at 1 year after inclusion in ESPOIR cohort is associated with better 3-year structural outcomes.

Ruyssen-Witrand A, Guernec G, Nigon D, Tobon G, Jamard B, Rat AC, Vittecoq O, Cantagrel A, Constantin A. Ruyssen-Witrand A, et al. Ann Rheum Dis. 2015 Sep;74(9):1676-83. doi: 10.1136/annrheumdis-2013-204906. Epub 2014 May 2. Ann Rheum Dis. 2015. PMID: 24794151

8

Prevalence of ultrasound-detected residual synovitis and risk of relapse and structural progression in rheumatoid arthritis patients in clinical remission: a systematic review and meta-analysis.

Nguyen H, Ruyssen-Witrand A, Gandjbakhch F, Constantin A, Foltz V, Cantagrel A. Nguyen H, et al. Rheumatology (Oxford). 2014 Nov;53(11):2110-8. doi: 10.1093/rheumatology/keu217. Epub 2014 Jun 13. Rheumatology (Oxford). 2014. PMID: 24929634 Review.

9

A new classification of HLA-DRB1 alleles based on acid-base properties of the amino acids located at positions 13, 70 and 71: impact on ACPA status or structural progression, and meta-analysis on 1235 patients with rheumatoid from two cohorts (ESPOIR and EAC cohort).

Ruyssen-Witrand A, van Steenbergen HW, van Heemst J, Gourraud PA, Nigon D, Lukas C, Miceli-Richard C, Jamard B, Cambon-Thomsen A, Cantagrel A, Dieudé P, van der Helm-van Mil AH, Constantin A. Ruyssen-Witrand A, et al. RMD Open. 2015 Nov 19;1(1):e000099. doi: 10.1136/rmdopen-2015-000099. eCollection 2015. RMD Open. 2015. PMID: 26629363 Free PMC article.

10

Predictive value of autoantibodies from anti-CCP2, anti-MCV and anti-human citrullinated fibrinogen tests, in early rheumatoid arthritis patients with rapid radiographic progression at 1 year: results from the ESPOIR cohort.

Degboé Y, Constantin A, Nigon D, Tobon G, Cornillet M, Schaeverbeke T, Chiocchia G, Nicaise-Roland P, Nogueira L, Serre G, Cantagrel A, Ruyssen-Witrand A. Degboé Y, et al. RMD Open. 2015 Nov 26;1(1):e000180. doi: 10.1136/rmdopen-2015-000180. eCollection 2015. RMD Open. 2015. PMID: 26635969 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

106 results

Search Page